• No results found

The significance of programmed cell death ligand 1 expression in resected lung adenocarcinoma

N/A
N/A
Info
Download
Protected

Academic year: 2020

Share "The significance of programmed cell death ligand 1 expression in resected lung adenocarcinoma"

Copied!
9
0
0

Loading.... (view fulltext now)

Download now ( 9 Page )

Full text

Figure

Figure 1: Representative results of PD-L1 expression in lung adenocarcinoma. (A) Positive result of PD-L1 examined via immunohistochemistry method
Figure 2: Prognostic significance of PD-L1 expression in lung adenocarcinoma. (A) Recurrence free survival in patients with positive or negative programmed cell death ligand (PD-L1) expression

References

Download now ( PDF - 9 Page - 1.27 MB )

Related documents

Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay

HNSCC: head and neck squamous cell carcinoma; IC: tumor-infiltrating immune cells; IHC: immunohistochemistry; NSCLC: non- small cell lung cancer; PD-L1: programmed cell death

Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report

ALCL: Anaplastic large cell lymphoma kinase; ALCL, ALK: ALK-negative anaplastic large cell lymphomas; ALK: Anaplastic large cell lymphoma kinase; BIA-ALCL: Breast

An eight miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma

ALK: Anaplastic lymphoma kinase; AUC: Area under the respective ROC curves; EGFR: Epidermal growth factor receptor; FDR: False discovery rate; GLM: Generalized linear model; GO:

Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer

Efficacy and safety of ceritinib in patients with advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK + ) non-small cell lung cancer (NSCLC): an update of ASCEND-1..

lymphomas identifies a new target for radioimmunotherapyGiuseppe Gritti

AITL: Angioimmunoblastic lymphoma; ALCL: Anaplastic large cell lymphoma; ALK: Anaplastic large cell lymphoma kinase; CTCL: Cutaneous T-cell lymphoma; EGF: Epidermal growth

demonstrate improved quality of biomarker analysis in lung cancer

Abbreviations: ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; EQA, external quality assessment; FISH, fluorescence in situ hybridization; IHC,

Worse disease-free, tumor-specific, and overall survival in surgically-resected lung adenocarcinoma patients with ALK

Introduction: This study determined the prevalence of anaplastic lymphoma kinase (ALK) rearrangement, and identified the associations of ALK rearrangement with clinicopathologic

Programmed death ligand 1 immunohistochemistry in non-small cell lung carcinoma

PD-L1, programmed death ligand 1; NSCLC, non-small cell lung carcinoma; FKS, Fleiss kappa statistic; IC, immune cells; ICC, intraclass correlation coefficient; TC, tumor cells;